After that, increasing studies focused on the association between NOD2 polymorphisms and risks of various cancers including gastric cancer, colorectal cancer, endometrial cancer, breast cancer, ovarian cancer, laryngeal cancer and so on. Here, NOD2 is linked to ovarian carcinoma.